# The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of Tcells

> **NCT03057340** · PHASE1 · UNKNOWN · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 30 (estimated)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **BIOLOGICAL:** Dribble vaccine

## Key facts

- **NCT ID:** NCT03057340
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-01
- **Primary completion:** 2019-12-01
- **Final completion:** 2020-12-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03057340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03057340, "The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of Tcells". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03057340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*